PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology

"AI has the potential to transform cancer care, but its progress has been held back by fragmented and inaccessible data," said Professor Anita Grigoriadis, CEO of PharosAI and Professor of Molecular and Digital Pathology at King's College London. "PharosAI changes that - creating rich, multimodal datasets and pairing them with cutting-edge AI models and analytical tools, powered by 10x Genomics' advanced spatial technologies to enable earlier diagnoses, more targeted therapies and better outcomes for patien ...